These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25752895)

  • 41. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
    Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
    J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
    Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
    J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
    Cummings LC; Payes JD; Cooper GS
    Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.
    Tufo A; Dunne DFJ; Manu N; Joshi H; Lacasia C; Jones L; Malik HZ; Poston GJ; Fenwick SW
    Eur J Surg Oncol; 2018 Jul; 44(7):1040-1047. PubMed ID: 29456045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
    Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
    Wang K; Xu D; Yan XL; Poston G; Xing BC
    Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases.
    Sutton TL; Wong LH; Walker BS; Dewey EN; Eil RL; Ibewuike U; Chen EY; Rocha FG; Billingsley KG; Mayo SC
    J Surg Oncol; 2022 Jun; 125(8):1260-1268. PubMed ID: 35212404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver resection in patients with eight or more colorectal liver metastases.
    Viganò L; Capussotti L; Majno P; Toso C; Ferrero A; De Rosa G; Rubbia-Brandt L; Mentha G
    Br J Surg; 2015 Jan; 102(1):92-101. PubMed ID: 25451181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
    J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laparoscopic two-stage hepatectomy for bilobar colorectal liver metastases.
    Fuks D; Nomi T; Ogiso S; Gelli M; Velayutham V; Conrad C; Louvet C; Gayet B
    Br J Surg; 2015 Dec; 102(13):1684-90. PubMed ID: 26392212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma.
    Niu R; Yan TD; Zhu JC; Black D; Chu F; Morris DL
    Ann Surg Oncol; 2007 Jul; 14(7):2078-87. PubMed ID: 17473951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.
    Pathak S; Tang JM; Terlizzo M; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2010 Jan; 36(1):52-7. PubMed ID: 19879103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood loss and outcomes after resection of colorectal liver metastases.
    Margonis GA; Kim Y; Samaha M; Buettner S; Sasaki K; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 May; 202(2):473-80. PubMed ID: 27038662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients.
    Postlewait LM; Squires MH; Kooby DA; Weber SM; Scoggins CR; Cardona K; Cho CS; Martin RCG; Winslow ER; Maithel SK
    HPB (Oxford); 2016 Feb; 18(2):192-199. PubMed ID: 26902139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation.
    Leal JN; Bressan AK; Vachharajani N; Gonen M; Kingham TP; D'Angelica MI; Allen PJ; DeMatteo RP; Doyle MB; Bathe OF; Greig PD; Wei A; Chapman WC; Dixon E; Jarnagin WR
    J Am Coll Surg; 2016 May; 222(5):766-79. PubMed ID: 27113514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases.
    Akiyama T; Miyamoto Y; Imai K; Yamashita Y; Nomoto D; Daitoku N; Sakamoto Y; Kiyozumi Y; Tokunaga R; Eto K; Harada K; Hiyoshi Y; Iwatsuki M; Nagai Y; Iwagami S; Baba Y; Yoshida N; Baba H
    Ann Surg Oncol; 2020 Sep; 27(9):3534-3541. PubMed ID: 32648180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.